Search Within

Melissa Lynne Johnson

Formats
  1. Journal Article (11)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (18)
  2. Solid Tumor Oncology Division (18)
  3. Thoracic Oncology (15)
  4. Department of Pathology and Laboratory Medicine (9)
  5. Tow Center for Developmental Oncology (TCDO) (8)
  6. GSK Faculty (7)

More Groups

People
  1. Mark Kris (15)
  2. Gregory Riely (11)
  3. Camelia Sima (9)
  4. Marc Ladanyi (7)
  5. Christopher Azzoli (6)
  6. Vincent Miller (6)

More People

Years
  1. 2016 (2)
  2. 2013 (1)
  3. 2012 (1)
  4. 2011 (6)
  5. 2010 (4)
  6. 2009 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Journal of Thoracic Oncology (6)
  3. Annals of Oncology (2)
  4. Clinical Cancer Research (1)
  5. Lung Cancer (1)
  6. PLoS ONE (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Elsevier Inc. (7)
  3. Oxford University Press (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Ireland Ltd. (1)
  6. Public Library of Science (1)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung
    Meeting Abstract

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C.; Janjigian, Y. Y.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Analysis of a panel of serum biomarkers in patients with metastatic lung cancer
    Meeting Abstract

    Lou, E.; Johnson, M. L.; Sima, C.; Gonzalez-Espinoza, R.; Kris, M. G.; Azzoli, C. G.; Fleisher, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma
    Meeting Abstract

    Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations
    Meeting Abstract

    Johnson, M. L.; Rizvi, N. A.; Ginsberg, M. S.; Miller, V. A.; Kris, M. G.; Pao, W.; Riely, G. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)
    Meeting Abstract

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • A prospective study of serial measurements of cell-free DNA in plasma, radiographic response, and overall survival in patients with metastatic non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Johnson, M.; Morita, S.; Motoyama, K.; Subzwari, S.; Hsu, M.; Shen, R. L.; Danenberg, K.; Danenberg, P.; Kris, M. G.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Clinical and pathologic correlates in breast cancer (BC) brain metastasis (BM): Tissue microarray (TMA) studies
    Meeting Abstract

    Johnson, M. L.; Nehhozina, T.; Conlin, A. K.; Hsu, M.; Patil, S.; Jhaveri, K.; Hudis, C. A.; Brogi, E.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: Evidence and ongoing controversy
    Journal Article

    Wheler, J.; Johnson, M.; Seidman, A.
    Seminars in Oncology (2006)

    Fulltext@MSK | Save